voriconazole has been researched along with Electrocardiogram QT Prolonged in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 8 (88.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanretty, AM; Langelier, C; Trang, TP; Yang, K | 1 |
Gueta, I; Halkin, H; Kamari, Y; Livni, G; Loebstein, R; Markovits, N; Yarden-Bilavsky, H | 1 |
Johnson, MD; Mourad, A; Perfect, JR; Stiber, JA | 1 |
Gueta, I; Halkin, H; Loebstein, R; Markovits, N; Pasternak, Y; Shechter, N; Yarden-Bilavsky, H | 1 |
Ackerman, MJ; Barreto, JN; Cullen, MW; Dahl, NJ; Dierkhising, RA; Grove, ME; Mara, KC; Patnaik, MM; Sierzchulski, AG; Tosh, PK | 1 |
Atalay, S; Aypar, E; Çiftçi, E; Ileri, T; Ince, E; Kendirli, T; Tutar, E | 1 |
Cil, H; Elbey, MA; Islamoglu, Y; Onturk, E | 1 |
Estes, LL; Wilson, JW; Zeuli, JD | 1 |
Amedro, P; Blayac, JP; Cociglio, M; Eiden, C; Hillaire-Buys, D; Margueritte, G; Peyrière, H; Tichit, R | 1 |
1 trial(s) available for voriconazole and Electrocardiogram QT Prolonged
Article | Year |
---|---|
QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Leukemia; Long QT Syndrome; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Voriconazole | 2019 |
8 other study(ies) available for voriconazole and Electrocardiogram QT Prolonged
Article | Year |
---|---|
Use of isavuconazole in a patient with voriconazole-induced QTc prolongation.
Topics: Antifungal Agents; Cystic Fibrosis; Female; Humans; Long QT Syndrome; Lung Transplantation; Nitriles; Pyridines; Triazoles; Voriconazole; Young Adult | 2017 |
Voriconazole-induced QT prolongation among hemato-oncologic patients: clinical characteristics and risk factors.
Topics: Adult; Antifungal Agents; Electrocardiography; Female; Hematologic Neoplasms; Humans; Hypokalemia; Long QT Syndrome; Male; Middle Aged; Risk Factors; Voriconazole | 2017 |
Real-world implications of QT prolongation in patients receiving voriconazole and amiodarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antifungal Agents; Drug Interactions; Female; Humans; Long QT Syndrome; Male; Middle Aged; Retrospective Studies; Voriconazole | 2019 |
Voriconazole-induced QTc prolongation in a paediatric population.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Humans; Long QT Syndrome; Male; Retrospective Studies; Risk Factors; Voriconazole | 2019 |
Voriconazole-induced QT interval prolongation and torsades de pointes.
Topics: Adolescent; Antifungal Agents; Child; Electrocardiography; Endocarditis; Female; Humans; Long QT Syndrome; Male; Pulmonary Aspergillosis; Pyrimidines; Torsades de Pointes; Triazoles; Trichosporonosis; Voriconazole | 2011 |
OTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy.
Topics: Adult; Antifungal Agents; Cardiac Pacing, Artificial; Cardiopulmonary Resuscitation; Electric Countershock; Electrocardiography; Electrolytes; Female; Humans; Long QT Syndrome; Mitral Valve Insufficiency; Nephrotic Syndrome; Pyrimidines; Rheumatic Heart Disease; Torsades de Pointes; Triazoles; Voriconazole | 2012 |
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole | 2013 |
Inherited long QT syndrome revealed by antifungals drug-drug interaction.
Topics: Acute Disease; Adolescent; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Female; Genotype; Humans; Injections, Intravenous; Leukemia, Myeloid; Long QT Syndrome; Mixed Function Oxygenases; Mucormycosis; Pyrimidines; Torsades de Pointes; Triazoles; Voriconazole | 2007 |